TD Cowen lowered the firm’s price target on Teladoc to $25 from $30 and keeps a Market Perform rating on the shares. The firm expects the key concerns for investors about the quarter will focus around BetterHelp’s long-term growth trajectory particularly as it sees declining year-over-year growth.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on TDOC:
- Teladoc Health Announces Employee Inducement Awards under NYSE Rule 303A.08
- Teladoc call volume above normal and directionally bullish
- Cathie Wood’s ARK Investment bought 351.1K shares of Teladoc today
- Teladoc appoints Evans to board of directors
- 77% of Employers Plan to Increase Investment in Virtual Health Care, says Teladoc Health’s 2023 Virtual Care Transformation Index